Danielle Marie Gray alias Dr. Inflammation Inferno

Danielle Marie Gray is not licensed or approved by Pennsylvania State Board of Chiropractic to diagnose, treat, or cure Is Reiki effective for anxiety or depression?.

Is Reiki effective for anxiety or depression?

No specific health claims of theirs were cross-checked against the literature.

In their own wordsView sourceArchived copy

“Is Reiki effective for anxiety or depression?”

Rule: 63 P.S. § 625.102; 63 P.S. § 625.302

Danielle Marie Gray is not licensed or approved by Pennsylvania State Board of Chiropractic to diagnose, treat, or cure Lyme Disease.

Lyme Disease

Supports

There is no high-quality evidence from randomized trials, systematic reviews, or major guidelines showing that chiropractic treatment can eradicate Borrelia infection, modify the course of acute Lyme disease, or serve as a primary disease-directed therapy. ^[2][6][7][9] Major Lyme disease guidelines (e. g. , IDSA/AAN/ACR, CDC, NICE, recent guideline summaries) uniformly recommend antibiotics such as doxycycline, amoxicillin, cefuroxime, or ceftriaxone as the evidence-based treatment for Lyme disease, with treatment durations tailored to the clinical manifestation; they do not list chiropractic care as a disease-specific therapy. ^{[1][3][10][11][12]} From an evidence-rating perspective (e. g. , GRADE methodology), effective Lyme disease treatments are those with proven antimicrobial activity and demonstrated benefit in controlled studies, which chiropractic techniques lack. Chiropractic or other musculoskeletal therapies may have a role in symptomatic management of nonspecific pain or tension-type headaches in general, but this is indirect and not specific to Lyme disease, and existing headache guidelines emphasize pharmacologic and behavioral approaches rather than chiropractic as core treatment. ^[4]

Contradicts

Major clinical guidelines and reviews on Lyme disease consistently state that appropriate antibiotic therapy is required to treat the infection and prevent or reduce complications, and they do not endorse chiropractic treatment as a substitute or primary therapy. ^{[2][3][4][5][7][10][11][12]} Infectious disease guidelines also explicitly advise against non-evidence-based or prolonged non-antibiotic regimens for presumed chronic Lyme without clear diagnostic support, underscoring that non-antimicrobial modalities cannot be relied upon to clear infection. ^[1] The general framework for rating evidence quality and clinical recommendations (e. ^[6] g. , GRADE) would classify chiropractic treatment for Lyme disease as very low-quality or unsupported, since there are no controlled trials, no biologically plausible antimicrobial mechanism, and no guideline endorsement. Furthermore, Lyme disease is a systemic bacterial infection; standard medical texts and guidelines emphasize antibiotic treatment and, for neurologic or cardiac involvement, specific intravenous regimens, again with no mention of chiropractic care as disease-modifying therapy. ^[9]

Mainstream view

The mainstream medical and scientific position is that Lyme disease is a bacterial infection (usually Borrelia burgdorferi) that requires timely diagnosis and evidence-based antibiotic therapy to treat the infection and prevent complications. ^{[1][6][7][12]} Recommended treatments include oral doxycycline, amoxicillin, cefuroxime, or azithromycin for early localized or some disseminated forms, and intravenous ceftriaxone or similar agents for certain neurologic or cardiac manifestations, with durations typically between 10 and 28 days depending on the clinical presentation. ^[2] Chiropractic care is not recognized as a disease-directed treatment for Lyme disease; at most, it may be considered an adjunctive option for general musculoskeletal pain or functional complaints, provided it does not delay or replace appropriate antibiotic therapy. ^[5][10] Mainstream guidelines do not list chiropractic treatment among recommended interventions for Lyme disease, and evidence-based practice frameworks would regard claims that chiropractic can treat or cure Lyme disease as unsupported. ^[9][11]

In their own wordsView sourceArchived copy

“Lyme Disease”

Rule: 63 P.S. § 625.102

See every doc bro advertising Lyme disease

Danielle Marie Gray is not licensed or approved by Pennsylvania State Board of Chiropractic to diagnose, treat, or cure Rheumatoid Arthritis.

Rheumatoid Arthritis

Supports

The only supportive evidence I found is weak and indirect: a small 2015 systematic review of non-invasive manual therapy in rheumatoid arthritis reported limited evidence for manipulation, mobilisation, massage, and exercise, and concluded that most such interventions require further high-quality research before confident clinical use. ^{[2][6][7][13][14][16]} Some narrative or low-level sources suggest possible symptom relief, but they do not establish efficacy for rheumatoid arthritis treatment and are not high-quality evidence.

Contradicts

The best available evidence and guidance do not support chiropractic treatment as a rheumatoid arthritis therapy. ^{[4][6][7][13][16]} A 2022 ACR guideline states that using chiropractic therapy is conditionally recommended against, noting the absence of evidence for direct management of RA. ^[1][15] The physiotherapy guideline source also advises against manual cervical spine manipulation in RA because of possible cervical instability, and it states that evidence for passive mobilization is insufficient. A review of chiropractic care for arthritis reports no evidence for rheumatoid arthritis and highlights potential adverse effects. ^[14] The safety concern is especially relevant because cervical spine manipulation can be contraindicated in RA due to atlanto-axial instability.

Mainstream view

Mainstream rheumatology considers chiropractic care, especially spinal manipulation, not to be a disease-modifying or evidence-based treatment for rheumatoid arthritis. ^{[1][13][14][15]} Standard RA care is pharmacologic disease control with DMARDs and, when appropriate, adjunctive exercise/rehabilitation; manual therapy may sometimes be considered only cautiously for symptom relief and not during active inflammation or when cervical instability is present. ^[5][7][16]

In their own wordsView sourceArchived copy

“Rheumatoid Arthritis”

Rule: 63 P.S. § 625.102

See every doc bro advertising Autoimmune disease

Danielle Marie Gray is not licensed or approved by Pennsylvania State Board of Chiropractic to diagnose, treat, or cure Multiple Sclerosis.

Multiple Sclerosis

Supports

Multiple licensed disease-modifying treatments exist for multiple sclerosis, particularly for relapsing forms, and ocrelizumab is licensed for selected early primary progressive disease; major guidelines recommend treatment selection, monitoring, switching, and stopping strategies. ^{[17][19][20][21][22][23][24][25][26][27]} The cited systematic review found that several disease-modifying therapies reduce relapses, MRI disease activity, or progression in relapsing-remitting MS, and that ocrelizumab probably reduces progression in primary progressive MS. The cited molecular and therapeutic review describes established pharmacological interventions for MS.

Contradicts

The phrase is not a complete claim about a specific treatment, indication, country, or outcome. The cited papers on optic neuritis, encephalitis, MRI diagnosis, and McDonald diagnostic criteria do not establish licensing or efficacy of a particular MS treatment. ^{[17][18][19][20][22]} The paper on repurposing licensed Epstein-Barr-virus-active drugs presents a systematic approach and does not show that those drugs are licensed treatments for MS. ^[24][25][26] One listed paper concerns SOD1 ALS rather than MS and is irrelevant to this claim. ^[23]

Mainstream view

Multiple sclerosis has numerous licensed disease-modifying therapies, but licensing is indication- and jurisdiction-specific, and these treatments generally reduce relapses, new MRI lesions, and/or disability progression rather than cure MS. ^{[19][20][21][24][25][26][27]} Treatment should be individualized by MS subtype, disease activity, risks, comorbidities, and patient preferences. ^[17][23] As written, the fragment does not identify what treatment is being claimed, so it cannot be validated as a specific influencer claim.

In their own wordsView sourceArchived copy

“Multiple Sclerosis”

Rule: 63 P.S. § 625.102

See every doc bro advertising Multiple sclerosis

Danielle Marie Gray is not licensed or approved by Pennsylvania State Board of Chiropractic to diagnose, treat, or cure Fibromyalgia.

Fibromyalgia

Supports

The claim is a general topic rather than a specific intervention or outcome, but reliable guidance supports providing people with fibromyalgia emotional support, practical help with daily tasks, education, and connection with healthcare professionals and support resources. ^[29] The 2025 patient guideline specifically identifies family and friends as sources of emotional support and help with daily activities. Evidence also supports helping the person engage, according to their abilities and preferences, with individualized education, exercise, psychological therapies, and multidisciplinary care; systematic reviews find benefits for pain, function, quality of life, sleep, or mood, although certainty varies. ^[30][31][32]

Contradicts

None of the supplied index records directly evaluates how a loved one should support someone with fibromyalgia; they are unrelated clinical-trial registrations. ^[29][32] Evidence for specific caregiver behaviors, communication techniques, or caregiver-led treatment effects is therefore not established by the index list. Support should not be coercive or assume that exercise, activity, or any single treatment is appropriate for everyone, because fibromyalgia symptoms and responses are heterogeneous and much nonpharmacological evidence is low or moderate certainty.

Mainstream view

Supporting a loved one with fibromyalgia generally means believing and validating their symptoms, listening to their preferences, helping with practical tasks when requested, encouraging appropriate medical care and self-management without pressure, and adapting activity to fluctuating symptoms. ^[29][31][32] Education, individualized exercise or rehabilitation, psychological approaches, sleep management, and multidisciplinary care may help, but family support complements rather than replaces professional assessment and treatment. Because the claim is only a heading and gives no specific advice, its factual accuracy cannot be judged as a particular recommendation.

In their own wordsView sourceArchived copy

“Fibromyalgia”

Rule: 63 P.S. § 625.102

See every doc bro advertising Chronic fatigue and fibromyalgia

Danielle Marie Gray is not licensed or approved by Pennsylvania State Board of Chiropractic to diagnose, treat, or cure chronic fatigue.

chronic fatigue

Supports

Licensed clinicians can provide individualized symptom management for chronic fatigue or ME/CFS, including treatment of sleep problems, pain, orthostatic intolerance, and comorbid conditions. ^[42][43][44] Some prescription medicines may be used for associated symptoms, but this is not the same as a licensed treatment for chronic fatigue itself. The listed index papers concern B-cell malignancies, respiratory papillomatosis, primary biliary cholangitis, EBV, bronchiectasis, and immune thrombocytopenia, and do not support treatment of chronic fatigue . ^{[33][34][35][36][37][38][39][40][41]}

Contradicts

For ME/CFS specifically, the CDC states that there is no cure or FDA-approved treatment, and that care focuses on symptom relief and self-management rather than a disease-modifying licensed treatment. ^{[39][40][41][42][43][44]} Major guidance recommends individualized activity management or pacing and symptom-directed care; NICE advises against fixed-increment graded exercise therapy and limits cognitive behavioral therapy to supportive use. Therefore, the claim provides no identifiable treatment, indication, or outcome and is not supported by the cited papers or established guidance.

Mainstream view

There is no universally licensed or approved treatment that cures or specifically treats chronic fatigue syndrome/ME/CFS. ^[43][44] Clinicians evaluate alternative causes of fatigue and manage confirmed comorbidities and symptoms individually, while avoiding interventions that worsen post-exertional malaise. ^[42] The phrase licensed treatment of Chronic fatigue is too vague to identify a specific intervention or medically testable outcome. ^[40]

In their own wordsView sourceArchived copy

“chronic fatigue”

Rule: 63 P.S. § 625.102

See every doc bro advertising Chronic fatigue and fibromyalgia

Danielle Marie Gray is not licensed or approved by Pennsylvania State Board of Chiropractic to diagnose, treat, or cure psoriatic arthritis.

psoriatic arthritis

Supports

High-quality evidence for psoriatic arthritis focuses on pharmacologic immunomodulatory therapies, not chiropractic care. Large randomized controlled trials and network meta-analyses show substantial benefit from IL‑17, IL‑23 and IL‑12/23 inhibitors and other biologic DMARDs for joint symptoms, skin disease and prevention of radiographic progression, which are the cornerstone of PsA management, not manual spinal manipulation.^{[11][16][19][23]} Non‑pharmacological measures such as exercise, physical therapy, occupational therapy, weight loss, smoking cessation, massage and acupuncture are conditionally recommended in major guidelines as adjuncts, and can modestly improve pain, function and quality of life, but chiropractic is not specifically endorsed.^{[11][17][18][20][22][23]} There is extremely limited direct evidence: an older case report describes chiropractic management of a patient with combined osteoarthritis and psoriatic arthritis with reported pain and functional improvement, but this is uncontrolled, single‑patient data and not high‑quality evidence.^[24] Overall, there is no systematic review, randomized trial, or major guideline demonstrating that chiropractic treatment modifies the inflammatory or structural course of psoriatic arthritis.

Contradicts

Major rheumatology guidelines (ACR/NPF, EULAR, GRAPPA) consistently emphasize early initiation of conventional synthetic DMARDs and biologic or targeted synthetic DMARDs for active psoriatic arthritis, with non‑pharmacologic modalities only as adjunctive care; chiropractic manipulation is not listed among recommended treatments.^{[11][16][17][19][23]} These guidelines explicitly note that evidence for non‑pharmacological therapies (including physiotherapy, massage, acupuncture, exercise) is generally low quality and conditionally recommended, underscoring that such approaches should not replace disease‑modifying drug therapy.^[17][20][23] Available non‑pharmacologic evidence relates to general physical therapy or osteopathic/manual therapy and shows, at best, modest symptomatic relief in small, uncontrolled or pilot studies, without evidence of disease modification; the osteopathic treatment study in PsA showed some improvements in fatigue and joint pain but with high variability and no controlled design.^[24] There are no high‑quality data showing that chiropractic can control synovitis, enthesitis, prevent erosions or progression, or reduce the need for DMARDs, which contradicts any strong claim that chiropractic treatment is an effective primary therapy for psoriatic arthritis. Safety has also not been rigorously evaluated in PsA populations, so promoting chiropractic as a main treatment is not evidence‑based.

Mainstream view

The mainstream medical position is that psoriatic arthritis is a chronic, immune‑mediated inflammatory arthritis requiring a treat‑to‑target strategy with early use of conventional synthetic DMARDs (such as methotrexate) and escalation to biologic or targeted synthetic DMARDs (e.g., TNF, IL‑17, IL‑23, IL‑12/23 inhibitors, JAK inhibitors) to achieve remission or low disease activity and prevent structural damage.^{[11][16][17][18][19][23]} Non‑pharmacological interventions—exercise, physical/occupational therapy, weight loss in overweight patients, smoking cessation, and sometimes massage or acupuncture—are recommended as adjuncts to improve pain, function, fatigue and overall health but are not considered disease‑modifying and should not replace pharmacologic therapy.^{[11][17][18][20][22][23]} Chiropractic care is not specifically recommended in major psoriatic arthritis guidelines, and any use of manual or spinal manipulation would be viewed, at best, as optional, symptom‑focused adjunct care undertaken with caution and in coordination with a rheumatologist, rather than as a primary or disease‑modifying treatment.

In their own wordsView sourceArchived copy

“psoriatic arthritis”

Rule: 63 P.S. § 625.102

See every doc bro advertising Autoimmune disease

Danielle Marie Gray is not licensed or approved by Pennsylvania State Board of Chiropractic to diagnose, treat, or cure Heart disease.

Heart disease

Supports

High-quality heart disease guidelines emphasize evidence-based pharmacologic therapy, lifestyle modification, and management of risk factors such as hypertension, diabetes, lipids, and diet; they do not include chiropractic care as a treatment modality for heart disease or cardiovascular outcomes. ^{[1][2][6][8][49][51]} The hypertension guideline update highlights antihypertensive drugs, lifestyle changes, and structured risk-factor control as the basis of blood-pressure and cardiovascular risk management, with no role for chiropractic manipulation. ^[4][52] A small randomized, double-blind, placebo-controlled trial of atlas vertebra realignment in stage 1 hypertension reported that a specific upper cervical chiropractic procedure produced marked and sustained reductions in blood pressure comparable to two-drug therapy, suggesting a potential effect on blood pressure regulation in a very narrow context but not on broader heart disease outcomes. ^[7][50] Another small randomized controlled trial of thoracic chiropractic adjustments reported short-term reductions in systolic and diastolic blood pressure and pulse rate, again limited to surrogate measurements rather than hard cardiovascular endpoints. Outside of these small surrogate-outcome trials, most randomized trials of spinal manipulation in musculoskeletal conditions show either no cardiovascular autonomic effect or only modest HRV changes, and they are not designed to treat heart disease itself.

Contradicts

Evidence-based cardiovascular guidelines and major position statements do not recognize chiropractic treatment as a therapy for heart disease, coronary artery disease, heart failure, or arrhythmias; recommended treatments are medications, interventional procedures, cardiac rehabilitation, risk-factor modification, and nutrition interventions. ^{[1][5][6][7][8][50]} The ASPEN-FELANPE and ESPEN nutrition guidelines illustrate that even supportive care for systemic disease (including cardiovascular comorbidity) focuses on clinical nutrition and medical management, not chiropractic interventions. ^[2][3] Trials of spinal manipulation show either no specific effect on cardiovascular autonomic activity or only small changes in heart rate variability without changes in blood pressure, and they do not demonstrate reduced cardiovascular events, mortality, or structural heart disease improvement. Some literature and expert commentary emphasize potential safety concerns around cervical manipulation and cervical arterial dissection, highlighting that any association with stroke remains uncertain but warrants caution, which further undermines the idea of chiropractic treatment as a primary modality for heart disease. ^{[4][49][51][52]} Overall, there is no robust body of randomized trials, meta-analyses, or guidelines demonstrating that chiropractic care treats, reverses, or clinically improves heart disease outcomes such as myocardial infarction, heart failure progression, or atrial fibrillation burden compared with established medical therapies.

Mainstream view

The mainstream medical and scientific position is that heart disease should be managed with guideline-directed medical therapy, lifestyle modification, cardiac rehabilitation, and, when indicated, interventional or surgical procedures, not with chiropractic treatment. ^{[3][4][5][7][8][49][50][51]} Hypertension, a key risk factor for heart disease, is treated with lifestyle measures and antihypertensive medications according to large evidence-based guidelines; small chiropractic blood pressure trials are viewed as exploratory and insufficient to alter practice. ^[1][2][6] Major cardiology and internal medicine guidelines do not list chiropractic manipulation as a recommended or optional therapy for coronary artery disease, heart failure, valvular disease, or arrhythmias, and chiropractic is not included in standard cardiac rehabilitation programs, which instead rely on supervised exercise, nutrition, psychosocial support, and risk-factor control. ^[52] Chiropractic care may have a role in musculoskeletal pain management, but it is not considered a treatment for heart disease itself, and any claims that it can treat or reverse heart disease are regarded as unsupported by high-quality cardiovascular evidence.

In their own wordsView sourceArchived copy

“Heart disease”

Rule: 63 P.S. § 625.102

See every doc bro advertising Heart disease and cholesterol

Danielle Marie Gray is not licensed or approved by Pennsylvania State Board of Chiropractic to diagnose, treat, or cure High cholesterol.

High cholesterol

Supports

High-quality evidence supports chiropractic care for some musculoskeletal pain conditions, but not for lowering cholesterol. ^[6][56] A systematic review of spinal manipulative therapy for non-musculoskeletal disorders found no evidence of benefit for conditions such as hypertension and concluded that spinal manipulation was not superior to sham for the non-musculoskeletal disorders studied. ^[1][7][55] A systematic review focused on primary or early secondary prevention found no evidence that chiropractic treatment prevents or improves non-musculoskeletal disease in general. ^[53] Evidence that sometimes gets cited in favor of chiropractic care for cholesterol consists mainly of a retrospective case series in chiropractic patients receiving a nutritional program and isolated case reports, which are low-quality and do not establish a chiropractic effect on cholesterol. ^[54]

Contradicts

The claim is contradicted by the lack of randomized trial or guideline evidence showing that chiropractic treatment lowers total cholesterol, LDL-C, or cardiovascular risk. ^[1][4][6] The available systematic reviews found no credible preventive or disease-modifying effect of chiropractic treatment for non-musculoskeletal disorders. ^[53][56] The positive cholesterol changes reported in some chiropractic-adjacent reports were associated with a nutrition program or single-patient cases, not with chiropractic adjustment itself, so they cannot be generalized to treatment of high cholesterol. ^[5][54] The peer-reviewed index papers provided by the user are not directly about cholesterol management, and none provide evidence supporting chiropractic treatment for hypercholesterolemia.

Mainstream view

Mainstream medical and scientific guidance is that high cholesterol is treated with diet, physical activity, weight management, and, when indicated, lipid-lowering medications such as statins and other guideline-directed therapies. ^[1][5][54] Chiropractic treatment is not a recognized or evidence-based treatment for hypercholesterolemia, and there is no established mechanism or clinical evidence that spinal manipulation lowers cholesterol in a meaningful or reliable way. ^{[2][53][55][56]}

In their own wordsView sourceArchived copy

“High cholesterol”

Rule: 63 P.S. § 625.102

See every doc bro advertising Heart disease and cholesterol

Danielle Marie Gray is not licensed or approved by Pennsylvania State Board of Chiropractic to diagnose, treat, or cure Cancer risk.

Cancer risk

Supports

The claim is extremely vague (“Cancer risk”) and cannot be evaluated as a specific influencer recommendation, but the indexed papers collectively support the general scientific position that cancer risk is influenced by identifiable lifestyle, environmental, and clinical factors, and that some factors can increase or decrease risk depending on exposure and type of cancer. ^[61][66] The umbrella review of risk factors for endometrial cancer identifies multiple established risk factors (e. ^{[59][65][67][68]} g. , obesity, hormone-related factors), showing that specific exposures are associated with altered cancer risk at the population level. The umbrella review of Mediterranean diet and breast cancer reports that adherence to a Mediterranean dietary pattern is associated with reduced breast cancer risk, supporting the idea that certain dietary patterns can lower risk rather than generally “cause cancer. ^[60] ” The umbrella review on ovarian cancer risk factors similarly catalogues numerous environmental, reproductive, and lifestyle factors associated with ovarian cancer, reinforcing that cancer risk is multifactorial and quantifiable. ^[64] The umbrella review on cannabis use balances harms and potential benefits, indicating that any association with cancer risk must be judged in the context of dose, mode of use, and competing outcomes, rather than blanket statements that a single exposure simply “causes cancer. ^[57] ” The systematic review and meta-analysis of chemoradiotherapy for cervical cancer shows that while treatments are themselves toxic, they substantially improve survival compared with radiotherapy alone, supporting the mainstream view that for many cancers, appropriately used therapies reduce cancer-related mortality despite potential long-term risks. ^[58][62][63]

Contradicts

Because the claim is unspecified, high-quality evidence mainly contradicts oversimplified or absolute statements such as “X always causes cancer” or “Y is completely safe and has no impact on cancer risk. ^[66] ” Umbrella reviews of endometrial, ovarian, and breast cancer show wide ranges of risk estimates and evidence strengths, with many associations graded as weak or suggestive, indicating that cancer risk evidence is often probabilistic and heterogeneous rather than definitive for any one factor. ^{[58][60][61][62][64][65][67][68]} The Mediterranean diet umbrella review finds protective associations for some dietary patterns but not universal risk or protection across all foods, contradicting simplistic claims that entire broad categories (e. g. , all fats, all animal foods, all plant foods) uniformly increase or decrease cancer risk. The cannabis umbrella review highlights substantial uncertainty and mixed findings for many outcomes, illustrating that for some exposures, evidence for cancer risk is limited, conflicting, or indirect, which contradicts influencer-style assertions that rely on single mechanisms or small studies without accounting for overall evidence quality. ^[57][59] The cervical cancer chemoradiotherapy meta-analysis shows that, contrary to any claim that standard oncologic treatments inevitably worsen long-term cancer outcomes, combined chemoradiotherapy improves survival, and any secondary cancer risk must be balanced against large primary survival gains. ^[63]

Mainstream view

Mainstream oncology and public health view cancer risk as multifactorial: driven by a combination of non-modifiable factors (age, genetics) and modifiable factors (smoking, alcohol, obesity, infections, diet, physical inactivity, environmental exposures), and shaped by complex dose–response relationships and interactions across specific cancer types. ^[66] Large umbrella reviews of endometrial, breast, and ovarian cancer emphasize that risk factors and protective factors are cancer-type specific, that evidence strength varies widely, and that causality is better established for some exposures (e. ^{[58][59][60][62][64][65][67][68]} g. , obesity, hormone therapy, reproductive factors) than others. Major clinical guidelines, such as the ASCO guideline on venous thromboembolism in cancer, focus on managing treatment-related risks and complications rather than claiming that standard therapies themselves are avoidable causes of cancer, reflecting a mainstream emphasis on evidence-based trade-offs: reducing mortality and serious complications while acknowledging and mitigating therapy-related harms. ^[61] Overall, mainstream medicine rejects generic or absolute statements about “cancer risk” detached from specific exposures, doses, cancer sites, and levels of evidence, and instead relies on systematic reviews, meta-analyses, and guidelines to quantify risk and inform prevention and treatment strategies. ^[57][63]

In their own wordsView sourceArchived copy

“Cancer risk”

Rule: 63 P.S. § 625.102

Danielle Marie Gray is not licensed or approved by Pennsylvania State Board of Chiropractic to diagnose, treat, or cure Depression.

Depression

Supports

Depression has multiple licensed, evidence-based treatments, including antidepressant medication and psychotherapy recommended in clinical practice guidelines. ^[78][79] Internet-based cognitive behavioral therapy has evidence of efficacy for depression. ^[70] Augmentation strategies, ketamine or electroconvulsive therapy, and other interventions may benefit selected patients, particularly those with treatment-resistant depression. ^{[69][71][73][76]} Esketamine nasal spray is an approved treatment option for treatment-resistant depression, with studies reporting maintained response during longer-term treatment. ^{[72][74][77][80]}

Contradicts

The phrase "licensed treatment of Depression" is not a complete or specific clinical claim: it does not identify a particular treatment, jurisdiction, depression subtype, patient group, or outcome. ^{[71][72][73][74][76][78]} The listed studies support specific interventions, not an unspecified treatment. Psilocybin, deep-brain stimulation, and some forms of transcranial electrical stimulation remain investigational or have limited evidence and should not be assumed to be licensed treatments based on these papers. ^[69][75][79]

Mainstream view

Depression is a treatable medical disorder, but treatment should be selected after clinical assessment according to severity, diagnostic features, patient preferences, comorbidities, safety considerations, and prior response. ^{[69][71][72][73][74][76]} Established options include evidence-based psychotherapy and licensed antidepressant medications; electroconvulsive therapy and specialized treatments such as esketamine are reserved for appropriate indications. ^[70][79] A generic statement that there is a licensed treatment for depression is broadly true, but it is too vague to establish the safety, effectiveness, or licensing of any particular influencer-promoted intervention. ^[78]

In their own wordsView sourceArchived copy

“Depression”

Rule: 63 P.S. § 625.102

See every doc bro advertising Depression

Danielle Marie Gray is not licensed or approved by Pennsylvania State Board of Chiropractic to advertise Worry about Alzheimer’s and dementia as within their scope of practice.

Worry about Alzheimer’s and dementia

No specific health claims of theirs were cross-checked against the literature.

In their own wordsView sourceArchived copy

“Worry about Alzheimer’s and dementia”

Rule: 63 P.S. § 625.102

See every doc bro advertising Dementia and Alzheimer disease

Danielle Marie Gray is not licensed or approved by Pennsylvania State Board of Chiropractic to diagnose, treat, or cure Autoimmune Disease.

Autoimmune Disease

Supports

High-quality clinical evidence specifically showing that chiropractic treatment can modify autoimmune disease activity (e.g., reduce autoantibodies, prevent flares, induce remission) is essentially absent. A recent randomized controlled trial in people with subclinical spinal pain found that 12 weeks of chiropractic spinal adjustments altered blood biomarkers (increased BDNF and IL-6, decreased TNF-α, cortisol and IFN-γ), suggesting some modulation of inflammatory and neuroendocrine pathways, but this was in otherwise healthy individuals and not patients with autoimmune disease.^[11] A literature review of manual therapies (including chiropractic, osteopathic, and massage) reports various short-term changes in immune-related markers (cytokines, immunoglobulins, stress hormones), again largely in small experimental or physiological studies, not in autoimmune populations, and without clear clinical outcome data.^{[12][13][17][20]} Guidelines for autoimmune conditions such as inflammatory bowel disease emphasize evidence-based pharmacologic and nutritional management (e.g., ESPEN guideline for clinical nutrition in IBD) and do not include chiropractic manipulation as a disease-modifying treatment.^[2] Overall, current evidence supports at most that chiropractic and related manual therapies can induce short-term changes in immune and inflammatory biomarkers, but does not show clinically meaningful treatment effects on autoimmune disease activity or outcomes.

Contradicts

A systematic review assessing spinal manipulative therapy and infectious disease or immune outcomes concluded that there were no clinical studies showing that spinal manipulation prevents infectious disease or improves disease-specific outcomes, and that existing data only demonstrate short-term changes in biomarkers with unknown clinical relevance.^[14] A united statement from global chiropractic research leaders explicitly notes that there is no valid clinical scientific evidence that chiropractic care can meaningfully impact the immune system to prevent viral infections, and that claims that adjustments reduce risk of colds, flu, or other illnesses have never been properly tested.^[21] A review of spinal manipulative therapy’s biological effects found mixed and conflicting evidence about neuroimmunoendocrine changes, and emphasized that current mechanistic findings do not justify clinical claims about immune enhancement.^[17] Mainstream medical sources discussing chiropractic in rheumatoid arthritis report that there are no high-quality studies showing chiropractic is a safe or effective treatment for RA, that it does not affect the underlying autoimmunity, and that manipulation of inflamed joints may worsen symptoms.^[25] Major clinical guidelines for autoimmune and inflammatory conditions, such as nutrition guidelines in IBD, highlight pharmacologic therapies, nutrition, and other evidence-based interventions, with no role for chiropractic as a disease-modifying treatment.^[2] Together, these sources contradict strong claims that chiropractic can treat or control autoimmune disease, and indicate that any immune or inflammatory marker changes observed after manipulation have uncertain clinical significance.

Mainstream view

The mainstream medical and scientific position is that autoimmune diseases are primarily managed with evidence-based pharmacologic therapies (e.g., immunosuppressants, biologics), lifestyle measures, and condition-specific interventions guided by major clinical guidelines, and that chiropractic care is not an established disease-modifying treatment for autoimmunity.^[2] Chiropractic and other manual therapies may be used as adjuncts for musculoskeletal pain, stiffness, or functional complaints in some patients, but they are considered supportive or symptomatic rather than therapies that directly alter autoimmune pathophysiology or disease course.^[21][25] Current evidence on spinal manipulation shows short-term changes in some immune and inflammatory biomarkers, but systematic reviews emphasize that these findings do not translate into proven benefits in preventing disease, reducing autoimmune activity, or improving long-term clinical outcomes.^[11][14][17] Professional consensus statements from chiropractic researchers explicitly reject marketing claims that chiropractic care “boosts immunity” or prevents illness, and call for more rigorous trials before any such statements are made.^[14][21] For autoimmune diseases specifically (such as rheumatoid arthritis, lupus, multiple sclerosis, and inflammatory bowel disease), mainstream guidance does not recommend chiropractic as a primary treatment, and warns that manipulation of actively inflamed joints or unstable spines may pose risks.^[2][25]

In their own wordsView sourceArchived copy

“Autoimmune Disease”

Rule: 63 P.S. § 625.102

See every doc bro advertising Autoimmune disease

Danielle Marie Gray is not approved to offer Whole Body Cryotherapy (WBC) may provide potential relief from conditions like arthritis and auto immune conditions. within a Chiropractor scope of practice under Pennsylvania State Board of Chiropractic.

Whole Body Cryotherapy (WBC) may provide potential relief from conditions like arthritis and auto immune conditions.

Supports

There is randomized controlled trial evidence that whole body cryotherapy used as an adjunct to standard care can reduce pain and disease activity in patients with rheumatoid arthritis, an autoimmune inflammatory arthritis, at least in the short term.^[17] Observational and quasi-experimental studies in rheumatoid arthritis and osteoarthritis report reductions in pain scores, morning stiffness, and improvements in function after short series of whole body cryotherapy sessions, suggesting symptomatic benefit in these rheumatic conditions.^{[3][8][18][19][23]} A systematic review and meta-analysis of cryotherapy in inflammatory rheumatic diseases (including whole-body modalities) found statistically significant reductions in pain and disease activity scores in rheumatoid arthritis patients, supporting an analgesic and anti-inflammatory effect as adjunctive therapy.^[13][14] A broader narrative and scoping-style review of whole-body and partial-body cryotherapy concludes that whole body cryotherapy elicits systemic anti-inflammatory and analgesic effects and reports beneficial outcomes in rheumatic and osteoarticular diseases, fibromyalgia, multiple sclerosis and chronic pain, though it emphasizes the need for further controlled studies.^[21] More general musculoskeletal cryotherapy reviews indicate that cryotherapy can produce small reductions in pain intensity and modest functional gains in musculoskeletal conditions, consistent with the idea that cold exposure may offer limited short-term symptom relief.^[7][10]

Contradicts

The existing trials of whole body cryotherapy in rheumatoid arthritis are mostly small, short-term, single-center studies, often adjunctive to multimodal rehabilitation, which limits the ability to attribute benefits specifically to cryotherapy or to extrapolate to long-term disease control or broader autoimmune conditions. Some comparative studies show that whole body cryotherapy is not clearly superior to conventional local cryotherapy for pain relief or disease activity in rheumatoid arthritis, suggesting that any benefits may be modest and similar to standard cold therapies rather than unique to whole body exposure.^{[2][3][8][18]} Systematic reviews of cryotherapy for musculoskeletal pain report that benefits on pain and range of motion are small and may not reach clear clinical relevance, with low-certainty evidence for improvements in swelling or function, indicating that overall effect sizes are limited and the evidence base weak.^[7][10] The Cochrane review and other evidence on whole body cryotherapy for athletic recovery show no robust, clinically important advantages over other modalities, reinforcing that strong claims of broad therapeutic benefit are not supported by high-quality data.^[12][15] Major international guidelines for autoimmune diseases such as rheumatoid arthritis, inflammatory bowel disease, hypertension, or other systemic autoimmune conditions do not include whole body cryotherapy as a recommended disease-modifying or standard symptomatic therapy, underscoring that it is considered experimental or adjunctive at best.^{[2][3][13][14][20][22][24]} Evidence outside rheumatoid arthritis for autoimmune conditions more broadly (e.g., systemic autoimmune diseases, multiple sclerosis, systemic lupus) is sparse, largely observational, and insufficient to support confident claims about meaningful clinical improvement, remission, or reduced need for immunosuppressive therapy. Safety data for whole body cryotherapy are still limited, and long-term effects, optimal dosing, and contraindications in patients with cardiovascular comorbidities or severe autoimmune disease are not fully characterized.^[21]

Mainstream view

The mainstream medical position is that whole body cryotherapy may be used as an adjunctive physical modality to provide short-term symptomatic relief (particularly pain reduction and improved subjective function) in some patients with rheumatic conditions like rheumatoid arthritis and osteoarthritis, but it is not established as a primary or disease-modifying treatment for arthritis or autoimmune disease. Rheumatology guidelines and standard care pathways prioritize well-validated pharmacologic therapies (e.g., disease-modifying antirheumatic drugs, biologics), exercise, and conventional physical modalities, while whole body cryotherapy, when used, is typically considered an optional adjunct within rehabilitation programs rather than a core component of evidence-based management.^{[13][14][17][20][22][23]} For autoimmune conditions beyond inflammatory arthritis, mainstream clinicians regard whole body cryotherapy as experimental, with insufficient high-quality evidence to recommend it routinely; any use is generally confined to research settings or individualized adjunctive rehabilitation, with careful attention to contraindications and patient safety.^[21] Overall, the consensus is that while whole body cryotherapy can provide modest short-term symptomatic relief in certain arthritis populations, claims of broader or substantial benefit across autoimmune conditions are ahead of the evidence and should be presented cautiously, emphasizing its adjunctive, not curative, role.

In their own wordsView sourceArchived copy

“potential relief from conditions like arthritis and auto immune conditions”

Rule: 63 P.S. § 625.102; 49 Pa. Code § 5.14

See every doc bro advertising Autoimmune disease

Danielle Marie Gray is not licensed or approved by Pennsylvania State Board of Chiropractic to diagnose, treat, or cure Brain Span Inflammation Program.

Brain Span Inflammation Program

No specific health claims of theirs were cross-checked against the literature.

In their own wordsView sourceArchived copy

“Brain Span Inflammation Program further supports cognitive health by identifying and addressing factors contributing to systemic inflammation”

Rule: 63 P.S. § 625.102

Danielle Marie Gray is not approved to offer PEMF Therapy applies pulsed electromagnetic fields to stimulate cellular repair, energy production, and detoxification. within a Chiropractor scope of practice under Pennsylvania State Board of Chiropractic.

PEMF Therapy applies pulsed electromagnetic fields to stimulate cellular repair, energy production, and detoxification.

Supports

High-quality evidence shows that pulsed electromagnetic fields can modulate cellular processes involved in repair and metabolism, but support is specific and limited, not as broad as the influencer’s wording suggests. ^{[6][89][90][92]} Multiple in vitro and animal studies demonstrate that PEMF can enhance tissue repair processes (e. g. , bone, cartilage, tendon, skeletal muscle, wound healing) via effects on cell proliferation, migration, extracellular matrix synthesis, and modulation of inflammatory pathways. A 2023 study found PEMF accelerated skeletal muscle cell repair and wound closure in vitro and upregulated stress-response and antioxidant proteins, supporting a role in cellular repair mechanisms. Several reviews describe PEMF as promoting bone and joint healing and preserving extracellular matrix, partly through adenosine receptor signaling and downstream cascades that enhance anabolic and reparative pathways. ^[91] Other mechanistic work links PEMF exposure to activation of signaling pathways involved in osteogenesis, angiogenesis, and modulation of redox signaling, which are all relevant to tissue repair. There is emerging mechanistic evidence that PEMF can influence mitochondrial respiration and ATP-linked oxidative phosphorylation in experimental models. Recent work reports that PEMF can stimulate state 3 mitochondrial respiration (directly linked to ATP synthesis) and enhance ATP production in muscle or mitochondrial preparations, suggesting a plausible pathway for modest enhancement of cellular energy production. Some preclinical and small experimental studies report increased ATP generation, improved mitochondrial membrane potential, or enhanced electron transport chain activity after PEMF exposure, but these are early-stage data, often not yet confirmed in large, well-controlled human studies. Overall, there is mechanistic and preclinical support that PEMF can influence cellular repair pathways and may modestly affect mitochondrial energy metabolism under specific conditions and parameters. However, these data do not yet translate into broad, clinically proven systemic effects on “energy levels” in humans in the way influencers typically imply.

Contradicts

There is little to no high-quality evidence that PEMF “detoxifies” the body in the sense commonly used by wellness influencers (e. ^[6][90][92] g. , enhanced toxin clearance, liver detox, removal of unspecified toxins). Major guidelines and comprehensive clinical practice documents in internal medicine, cardiology, nutrition, and transfusion medicine do not mention PEMF as a detoxification or metabolic-cleansing therapy, nor do they list PEMF as a standard modality for systemic detoxification. For example, an evidence-based update on hypertension management focuses on lifestyle, pharmacologic therapy, and device-based interventions such as renal denervation but does not include PEMF as a recognized treatment or detox modality. ^[1] Clinical nutrition and metabolic-support guidelines (e. g. , ASPEN-FELANPE guidelines for critically ill adults and ESPEN guidelines for inflammatory bowel disease) discuss evidence-based strategies for supporting cellular function and organ detoxification (nutrition support, parenteral nutrition, organ-specific management) and do not include PEMF as a recommended therapy. ^[2][3][5] Blood transfusion therapy reviews and cardiology-focused pharmacologic interventions (such as colchicine in pericarditis) similarly do not identify PEMF as a detox or cell-repair standard of care. ^[7][8][89] High-quality evidence from systematic reviews and randomized trials in musculoskeletal indications generally evaluates pain, function, and structural healing, not systemic detoxification; these trials do not demonstrate that PEMF clinically enhances whole-body toxin clearance or general “detox. ” Even where mechanistic or preclinical studies suggest changes in redox balance, nitric oxide signaling, or inflammatory mediators, authors usually present these as local or pathway-specific effects, and they do not equate them with medical detoxification. ^[91] Overall, the detoxification aspect of the claim is unsupported by major guidelines, and human data are lacking or speculative. Evidence that PEMF consistently boosts cellular energy production in humans is also limited: most data are preclinical, with heterogeneous devices and parameters, and there is no robust body of large RCTs showing clinically meaningful increases in energy or metabolic capacity across conditions. Thus, claims of broad, generalized detox and energy enhancement go well beyond the current evidence base.

Mainstream view

The mainstream medical and scientific position is that PEMF is an adjunctive, niche therapy with some evidence for specific indications (most notably certain orthopedic and musculoskeletal conditions such as bone healing and possibly osteoarthritis and soft-tissue repair) but it is not established as a general therapy for global cellular repair, energy enhancement, or detoxification. ^{[6][7][89][90][91][92]} Regulatory approvals and guideline mentions, where they exist, are typically restricted to well-defined orthopedic indications and are based on device-specific clinical trials rather than broad systemic effects. ^[1][3] Major evidence-based clinical guidelines in cardiology, nutrition, critical care, neurology, and general internal medicine do not recommend PEM ^[2][5]

In their own wordsView sourceArchived copy

“PEMF Therapy applies pulsed electromagnetic fields to stimulate cellular repair, energy production, and detoxification”

Rule: 63 P.S. § 625.102; 49 Pa. Code § 5.14

Danielle Marie Gray is not approved to offer Hyperbaric Chamber Therapy delivers pure oxygen in a pressurized setting, supporting immune function, reducing fatigue, and enhancing tissue repair. within a Chiropractor scope of practice under Pennsylvania State Board of Chiropractic.

Hyperbaric Chamber Therapy delivers pure oxygen in a pressurized setting, supporting immune function, reducing fatigue, and enhancing tissue repair.

Supports

Hyperbaric oxygen therapy (HBOT) involves breathing nearly pure oxygen (typically 100% oxygen) at increased atmospheric pressure; this is standard in clinical and research descriptions of HBOT and underlies trials and protocols assessing HBOT for wound healing, long COVID, post‑concussion syndrome, and other conditions. ^{[2][7][93][94][95][96]} Multiple systematic reviews and randomized controlled trials report that HBOT can enhance tissue repair and wound healing in specific contexts, particularly chronic or difficult‑to‑heal wounds. A 2010 systematic review of difficult acute wounds and a 2013 Cochrane‑style review on acute surgical and traumatic wounds found that HBOT appeared beneficial in crush injuries and skin grafting, improving wound healing and reducing tissue necrosis, although trials were small and at risk of bias. A 2015–2024 body of meta‑analyses and systematic reviews focusing on diabetic foot ulcers (DFU) and chronic wounds report that adjunctive HBOT increases short‑term ulcer healing rates and reduces amputation risk, with more recent analyses (including a 2024 systematic review of 14 RCTs) concluding moderate‑quality evidence that HBOT improves wound healing and reduces minor and major amputations when used adjunctively in Wagner grade II–IV DFU. ^[5][6] A 2025 randomized trial combining HBOT with negative‑pressure wound therapy showed significantly higher wound‑healing rates than negative‑pressure therapy alone, and randomized trials in post‑traumatic split‑thickness skin grafts and hypospadias reconstruction report faster graft uptake, faster donor‑site healing, and increased VEGF (angiogenesis marker), all supporting enhanced tissue repair. HBOT has also been shown to modulate immune‐related parameters: recent translational work demonstrates that low‑dose HBOT in healthy subjects increases natural killer (NK) cell number and cytolytic activity without increasing systemic inflammatory markers, and an exploratory randomized trial in severe COVID‑19‑associated ARDS reports immunomodulatory changes and clinical outcomes consistent with reduced inflammation. ^[3] These data support the more cautious formulation that HBOT can have immunomodulatory effects and, in selected contexts, may improve host defense or inflammatory balance rather than a blanket claim that it “supports immune function” in all users. For fatigue, several clinical studies and systematic reviews in conditions such as fibromyalgia and long COVID report that HBOT can improve patient‑reported fatigue, energy, sleep quality, and quality of life compared with sham or usual care, although evidence is still emerging and often of low to moderate certainty. Post‑exercise and musculoskeletal recovery studies suggest that HBOT given during or after exercise can improve muscle oxygenation and reduce subjective fatigue and muscle damage markers, again in specific controlled settings rather than general everyday tiredness.

Contradicts

Although HBOT does deliver high‑concentration oxygen under pressure, the phrasing “pure oxygen” is somewhat imprecise; clinical HBOT generally uses medical grade 100% oxygen, but protocols and chamber environments vary, and this detail is less central than the pressure‑mediated increase in dissolved oxygen. ^{[2][93][94][95][96]} More importantly, high‑quality evidence does not support a broad, generalized claim that HBOT “supports immune function” for the average person. ^[6] Immune‑related HBOT studies are limited, often small, and focused on specific conditions (e. g. , severe infections, COVID‑19‑related ARDS, or experimental models), and major practice guidelines in internal medicine, hypertension, nutrition, and neurology do not list HBOT as a standard immune‑enhancing therapy, instead emphasizing established treatments and lifestyle interventions . ^[5][7] Where immune outcomes are reported, they are typically described as immunomodulation (e. g. , changes in NK cell activity or inflammatory markers) rather than a simple boost in immunity, and long‑term safety and generalizability are not well established. The evidence on fatigue reduction is mixed and condition‑specific. Systematic reviews of HBOT in exercise performance and recovery show that pre‑ or post‑exercise HBOT often has no significant effect on objective performance or muscle damage compared with normobaric conditions, with benefits mainly seen when HBOT is applied during exercise and/or in small, heterogeneous trials. A 2021 review concluded that HBOT before or after exercise did not significantly alter muscle damage or physiological responses versus normal air, and that only intra‑exercise HBOT improved muscle oxygenation and muscle fatigue, which limits its relevance to everyday clinical fatigue. In addition, a 2023 systematic review of HBOT adverse effects found that fatigue was reported as a side effect in some studies, with a nonsignificant

In their own wordsView sourceArchived copy

“Hyperbaric Chamber Therapy delivers pure oxygen in a pressurized setting, supporting immune function, reducing fatigue, and enhancing tissue repair”

Rule: 63 P.S. § 625.102

Danielle Marie Gray is not licensed or approved by Pennsylvania State Board of Chiropractic to diagnose, treat, or cure BrainTap HRV Testing.

BrainTap HRV Testing

No specific health claims of theirs were cross-checked against the literature.

In their own wordsView sourceArchived copy

“BrainTap HRV Testing evaluates heart rate variability, offering insights into autonomic nervous system function and resilience”

Rule: 63 P.S. § 625.102

Danielle Marie Gray is not approved to offer MedRay Class IV Laser Therapy penetrates deep into tissues to accelerate healing and reduce pain. within a Chiropractor scope of practice under Pennsylvania State Board of Chiropractic.

MedRay Class IV Laser Therapy penetrates deep into tissues to accelerate healing and reduce pain.

Supports

High-quality evidence supports low-level laser therapy as an adjunct for pain reduction and wound healing in some specific conditions, but the evidence is condition-specific rather than proof of a universal deep-penetrating healing effect. ^{[97][99][100]} A 2024 systematic review and meta-analysis of 18 RCTs in skin wounds found greater wound-size reduction, faster healing, and lower pain with LLLT versus control. ^[98] A 2023 systematic review and meta-analysis after gingivectomy also found better healing indices and lower postoperative pain on days 3 and 7. A 2024 meta-analysis in recurrent aphthous stomatitis found reduced pain in 13 of 14 trials and faster healing in pooled analyses, though with some concerns about bias. Broader evidence also shows pain benefits in some musculoskeletal conditions, including a meta-analysis of pain in adult musculoskeletal disorders and knee osteoarthritis.

Contradicts

The claim is stronger than the evidence because it says the device penetrates deep into tissues and accelerates healing and reduces pain as a general effect. ^[100] The available reviews mostly evaluate low-level laser therapy, not specifically MedRay Class IV laser therapy, and they do not establish that all class IV devices produce the same clinical outcomes. ^[97][99] Evidence is also mixed across conditions: one systematic review of breastfeeding-related nipple pain found no significant pain difference versus control in pooled analysis, and a review of temporomandibular joint dysfunction reported limited evidence with several trials showing no difference. ^[98] Even where benefits are reported, reviews repeatedly note small samples, heterogeneity, risk of bias, and the need for better RCTs. The claim of deep tissue penetration is a physics/device statement that is not established by the cited clinical outcome reviews, and the clinical literature here does not prove that greater penetration automatically translates into accelerated healing across tissues. The indexed paper list does not include a guideline or high-quality review specifically validating MedRay Class IV laser therapy for this general claim.

Mainstream view

Mainstream medical view: photobiomodulation/low-level laser therapy may provide modest short-term pain relief and may improve healing in selected indications, but evidence varies by condition, dosing, wavelength, and protocol, and it is not a universally proven deep-tissue healing treatment. ^{[97][98][99][100]} Major reviews generally view it as a possible adjunct rather than a stand-alone, broadly established therapy.

In their own wordsView sourceArchived copy

“MedRay Class IV Laser Therapy penetrates deep into tissues to accelerate healing and reduce pain”

Rule: 63 P.S. §625.101 et seq. (Chiropractic Practice Act)